Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
Nadia Stefanova(Innsbruck Medical University), Gregor K. Wenning(Innsbruck Medical University)
Cited by 78
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|788
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
|Glia|2012|700
The natural history of multiple system atrophy: a prospective European cohort study
|The Lancet Neurology|2013|533